CONNECT WITH US
Gaming

Gaming

PS Plus Bonus Freebies Officially Confirmed for October 20

Game Rant logo

Published on

Add as a preferred source on Google
PS Plus Bonus Freebies Officially Confirmed for October 20

Sony has officially confirmed two extra PlayStation Plus freebies for October 20. Both bonuses are trials rather than full games that PS Plus members can claim permanently.

Game trials are a benefit reserved for PS Plus Premium subscribers. While they typically remain available for years, few are truly permanent catalog additions, with Sony generally keeping them accessible until further notice rather than assigning fixed end dates. In this case, the company has not announced how long either of the new October 20 trials will remain available, which is consistent with its usual approach.

PlayStation Plus launches its complimentary games for October 2026, allowing subscribers to claim three very different titles worth $150 combined.

The October 20 additions are Mortal Shell 2 and Resonance: A Plague Tale Legacy. Both of them are fairly new releases, having originally launched in late summer 2026. Specifically, Resonance: A Plague Tale Legacy arrived on PC and consoles on August 27, while Mortal Shell 2 debuted seven days earlier. Both are also priced below the modern AAA average, at $49.99 for the Mortal Shell sequel and $59.99 for the latest A Plague Tale game. The latter currently has no free trial on any platform, whereas Mortal Shell 2 already offers one on PC and the Series X/S via Steam and the Xbox Store, respectively. Although technically marketed as an "open beta," it functions as a demo and has remained available since the game's launch.

Mortal Shell 2 is a standalone sequel to the 2020 soulslike from American studio Cold Symmetry.


Source link
Related Topics:Gaming

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.